{{Rsnum
|rsid=7931342
|Chromosome=11
|position=69227030
|Orientation=plus
|GMAF=0.4885
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 30.1 | 46.0 | 23.9
| HCB | 5.1 | 38.7 | 56.2
| JPT | 6.2 | 38.1 | 55.8
| YRI | 68.7 | 28.6 | 2.7
| ASW | 73.7 | 26.3 | 0.0
| CHB | 5.1 | 38.7 | 56.2
| CHD | 6.4 | 35.8 | 57.8
| GIH | 13.9 | 45.5 | 40.6
| LWK | 70.0 | 25.5 | 4.5
| MEX | 13.8 | 46.6 | 39.7
| MKK | 51.0 | 40.0 | 9.0
| TSI | 34.3 | 40.2 | 25.5
| HapMapRevision=28
}}[http://cancergenetics.wordpress.com/2008/02/15/prostate-cancer-oldnew-snps-and-decodeprca/ cancer-genetics] these snps influence genetic risk for [[prostate cancer]]
*the [[haplotype]] [[rs6983267]] [[rs1016343]] [[rs4242384]] 
*[[rs7501939]] 
*[[rs1859962]]
*[[rs2660753]]
*[[rs9364554]]
*[[rs6465657]]
*[[rs10993994]]
*[[rs7931342]]
*[[rs2735839]]
*[[rs5945619]]
*[[rs10993994]]

{{PMID|18974127|OA=1
}} [[rs7931342]]  showed some evidence of association with [[breast cancer]] (per minor allele OR, 0.95; 95% CI, 0.91-0.99; P(trend) = 0.028)

{{ neighbor
| rsid = 10896449
| distance = 170
}}

{{GWAS Summary
|SNP=rs7931342
|PubMedID=18264097
|Condition=Prostate cancer
|Gene=Intergenic
|Risk Allele=G
|pValue=2.00E-012
|OR=1.19
|95CI=1.11-1.27
}}
{{PMID Auto
|PMID=19336566
|Title=Replication of the 10q11 and Xp11 Prostate Cancer Risk Variants: Results from a Utah Pedigree-Based Study.
|OA=1
}}

{{omim
|desc=PROSTATE CANCER, HEREDITARY, 14; HPC14
|id=611958
|rsnum=7931342
}}

{{PharmGKB
|RSID=rs7931342
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:18264097; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS Results: Multiple newly identified loci associated with prostate cancer susceptibility (Initial Sample Size: 1,854 cases, 1,894 controls; Replication Sample Size: 3,268 cases, 3,366 controls; Risk Allele: rs7931342-G).
|Drugs=
|Drug Classes=
|Diseases=Prostatic Neoplasms
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356748
}}

{{PMID|18708398|OA=1
}} Multiple novel prostate cancer predisposition loci confirmed by an international study: the PRACTICAL Consortium.

{{PMID|19104501|OA=1
}} Prostate cancer genomics: towards a new understanding.

{{PMID|19318432|OA=1
}} Generalizability of associations from prostate cancer genome-wide association studies in multiple populations.

{{PMID|19366831|OA=1
}} Analysis of recently identified prostate cancer susceptibility loci in a population-based study: associations with family history and clinical features.

{{PMID|19505914|OA=1
}} Two independent prostate cancer risk-associated Loci at 11q13.

{{PMID|19567509|OA=1
}} Genetic variants and prostate cancer risk: candidate replication and exploration of viral restriction genes.

{{PMID|19639606|OA=1
}} Correcting "winner's curse" in odds ratios from genomewide association findings for major complex human diseases.

{{PMID|20690139}} Meta-analysis of genome-wide and replication association studies on prostate cancer.

{{PMID|21071540|OA=1
}} Validation of genome-wide prostate cancer associations in men of African descent.

{{PMID|21390317|OA=1
}} Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3.

{{PMID|21445969}} Significant associations of prostate cancer susceptibility variants with survival in patients treated with androgen-deprivation therapy.

{{PMID|21538423|OA=1
}} Early onset prostate cancer has a significant genetic component.

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs7931342
|overall_frequency_n=67
|overall_frequency_d=128
|overall_frequency=0.523438
|n_genomes=43
|n_genomes_annotated=0
|n_haplomes=61
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}